Search Results
Mar 18, 2026, 13:50 ET Evinature's CurQD Chosen for DoD-Funded Clinical Trial to Investigate Combination Approach for Ulcerative Colitis
than in the general population (Hou et al., Inflamm Bowel Dis, 2013). Environmental exposures unique to military service may be a contributing factor, according to the researchers who authored the grant application. A
More news about: Evinature
Mar 17, 2026, 15:00 ET Chega ao Brasil eplontersena para tratamento da amiloidose hereditária mediada por transtirretina com polineuropatia (ATTRv-PN)
doi:10.1001/jama.2023.18688 Ando Y, Coelho T, Berk JL, et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis. 2013;8:31. Wang Y, Yu RZ, Henry S, Geary RS. Pharmacokinetics and clinical pharmacology considerations of GalNAc3-conjugated
More news about: AstraZeneca
Mar 16, 2026, 08:00 ET Argo Biopharma Receives FDA Fast Track Designation for BW-20805, an Investigational siRNA Therapy for the Treatment of HAE
www.argobiopharma.com.References：Giavina-Bianchi P, et al. (2011). CLINICS 66(9): 1627–1636.Aygören-Pürsün, E, et al. (2018). Orphanet J Rare Dis 13(1): 73.
More news about: Argo Biopharmaceutical Co., Ltd
Mar 16, 2026, 04:30 ET Lundbeck advances Parkinson's research with new Phase 1b data at AD/PD™ 2026
LinkedIn.References:Heim B and Poewe W. J Parkinsons Dis 2025;23Cenci MA. Front Neurol 2014;5:242Stocchi F et al. Nat Rev Neurol 2024;20:695–707Jellinger KA. J Alzheimers Dis. 2018;62:1141–79This information was brought to you by Cision
More news about: H. Lundbeck A/S
Mar 16, 2026, 04:27 ET Lundbeck advances Parkinson's research with new Phase 1b data at AD/PD™ 2026
LinkedIn.References:Heim B and Poewe W. J Parkinsons Dis 2025;23Cenci MA. Front Neurol 2014;5:242Stocchi F et al. Nat Rev Neurol 2024;20:695–707Jellinger KA. J Alzheimers Dis. 2018;62:1141–79This information was brought to you by Cision
More news about: H. Lundbeck A/S
Mar 11, 2026, 10:17 ET Olympus Launches Next-Generation Surgical Imaging Platform in U.S.
Intraoperative Near-Infrared Observation on Anastomotic Leakage After Stapled Side-to-Side Anastomosis in Colon Cancer Surgery Using Propensity Score Matching. Dis Colon Rectum. 2021 Dec 1;64(12):1542-1550. doi: 10.1097/DCR.0000000000001960. PMID: 33661231.vi Verification test: Data on file with
More news about: Olympus Corporation of the Americas
Mar 11, 2026, 07:00 ET BIMZELX®▼(bimekizumab) superior to SKYRIZI® (risankizumab) in BE BOLD: first head-to-head study in active psoriatic arthritis (PsA) to demonstrate superiority in ACR50
Arthritis Care Res (Hoboken). 2020;72(Suppl 10):82–109.Ritchlin CT, et al. Ann Rheum Dis. 2023;82(11);1404–14.Felson DT, et al. Arthritis Rheum. 1995;38(6):727–35.Ogdie A, et al. Rheum Dis Clin North Am. 2015;41(4):545–68.About Psoriatic Arthritis. National Psoriasis Foundation.
More news about: UCB
Mar 05, 2026, 06:00 ET Maple Leaf Foods Reports Fourth Quarter and Full Year 2025 Financial Results
limited to the following:the benefits and impacts of the Spin-Off being realized, including the projected risks, costs, dis-synergies, and tax consequences;compliance by Maple Leaf Foods, Canada Packers and "specified shareholders", as defined in the Income Tax Act (''ITA"),
More news about: Maple Leaf Foods Inc.
Mar 04, 2026, 08:31 ET Huawei, Operatörleri Güçlendirmek için Yeni Nesil Yapay Zeka Destekli Yeşil Saha ve GW Seviyesinde AIDC Çözümlerini Piyasaya Sürdü
kolaylaştırmak için yüksek yoğunluklu, yüksek verimli ve güvenilir bir entegre PowerPOD çözümü geliştirdi.AIDC tam zincir soğutma: Huawei, çiplerden dış ortama ısı yayılımındaki yenilikler ve soğutma bağlantılarını ürünleştirerek, AIDC'lerin verimli ve son derece güvenilir soğutma elde etmelerine yardımcı
More news about: Huawei Digital Power
Mar 03, 2026, 07:30 ET Digital Investment Strategy Acquires Control of Slam Corp. and Announces Transition of Slam to Field Digital Corp.
co-founder of DIS, Mr. Shah brings more than 20 years of investment management experience, with senior roles as a Portfolio Manager at leading firms including Citadel, Millennium Management, and Perry Capital.Joseph Buttram assumes the role of Chief Executive Officer. A co-founder of DIS and founder
More news about: Field Digital Corp.
Mar 02, 2026, 08:30 ET AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn's Disease
Hepatol. 2015 Dec;12(12):720-7. doi: 10.1038/nrgastro.2015.150.Gajendran M, et al. A comprehensive review and update on Crohn's disease. Dis Mon. 2018 Feb;64(2):20-57. doi: 10.1016/j.disamonth.2017.07.001.A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab
More news about: AbbVie
Feb 27, 2026, 16:04 ET Copel registrou Ebitda Recorrente de R$ 1.358,1 milhões no 4T25, um crescimento de 16,1% frente aos R$ 1.169,6 milhões registrados no 4T24.
Companhia de gerar valor de forma consistente, apoiada na solidez de seus ativos e na execução eficiente de sua estratégia operacional e comercial. A Copel DIS representou aproximadamente 53,6% desse resultado, enquanto a Copel GeT e a Copel COM representaram aproximadamente 48,4%, compensado pelo resultado
More news about: Copel - Companhia Paranaense de Energia
Feb 25, 2026, 21:00 ET Argo Biopharma to Present Positive Phase II Interim Results of siRNA Therapeutic BW-20805 for HAE at the 2026 AAAAI Annual Meeting
www.argobiopharma.com.References：Giavina-Bianchi P, et al. (2011). CLINICS 66(9): 1627–1636.Aygören-Pürsün, E, et al. (2018). Orphanet J Rare Dis 13(1): 73.
More news about: Argo Biopharmaceutical Co., Ltd
Feb 25, 2026, 07:00 ET Joint U.S. Commercialization of RedHill's Talicia® Commences
Epidemiology, and End Results Program (SEER).[6] Malfertheiner, P., Camargo, M.C., El-Omar, E. et al. Helicobacter pylori infection. Nat Rev Dis Primers 9, 19 (2023). https://doi.org/10.1038/s41572-023-00431-8[7]
More news about: RedHill Biopharma Ltd.
Feb 19, 2026, 13:00 ET Fleetworthy Unifies Brands to Deliver Complete Fleet Readiness and Help Fleets Control Costs
operational efficiency.For government agency partners, Fleetworthy Infrastructure Solutions (FIS) is rebranded from Drivewyze Infrastructure Services (DIS). This product line continues to support the public sector with infrastructure and safety technology, including weigh station bypass infrastructure,
More news about: Fleetworthy
Feb 11, 2026, 09:15 ET From Herbs to Harmonics: Doctah B Sirius Ushers in a New Era with What's Eating You, an Integrated Book and Medicine Music Healing Experience
innate rhythm of wellness. His philosophy emphasizes that physical and emotional toxins, deficiencies, and parasites are foundational contributors to dis-ease, and that total-body reclamation is the gateway to vitality and freedom.For more than four decades, Doctah B Sirius has also pioneered sound
More news about: Doctah B Sirius
Feb 04, 2026, 08:55 ET NYSE Content Update: Disney Names New CEO After Ringing Bell on Main Street USA
as traders rotate into economically sensitive sectors. Small-cap stocks have benefited, and Gold returned to $5,000 an ounce.Disney (NYSE: DIS) announced yesterday that Josh D'Amaro will succeed longtime CEO Bob Iger, effective on March 18th, 2026. Iger and D'Amaro joined NYSE President Lynn
More news about: New York Stock Exchange
Jan 20, 2026, 06:30 ET 3M Reports Fourth-Quarter and Full-Year 2025 Results; Initiates Full-Year 2026 Financial Guidance
to the spin-off of the Company's Health Care business, including the risk that the expected benefits will not be realized; the risk that the costs or dis-synergies will exceed the anticipated amounts; potential impacts on the Company's relationships with its customers, suppliers, employees, regulators
More news about: 3M Company
Jan 20, 2026, 00:00 ET PioCreat, AEEDC Dubai 2026'ya Hasta Başı Dental 3D Baskı Çözümlerini Getiriyor
AEEDC Dubai, diş hekimleri, üreticiler ve teknoloji yenilikçileri için küresel bir merkez olarak tanınmaktadır. PioCreat'ın bu prestijli etkinliğe katılımı, küresel genişlemesi ve dijital diş hekimliğine verdiği önem açısından önemli bir dönüm noktasıdır.Temel
More news about: PioCreat 3D
Jan 13, 2026, 09:34 ET Toutes les choses qu'elles portent: ouverture de l'exposition le 29 janvier 2026 à La Galerie des Photographes, Paris
déplacent l'objectification en questionnant la manière dont le corps féminin est chargé d'attentes sociales et émotionnelles. Avec la série The (Dis-)Appearing Woman (2014–2015), Sarah Knill-Jones aborde l'oscillation entre apparition et disparition à travers des portraits peints partiellement
More news about: Toutes les choses qu’elles portent; All The Things They Carry
Jan 13, 2026, 09:26 ET All the Things They Carry: Exhibition opening 29 January 2026 at La Galerie des Photographes, Paris
challenge objectification by questioning the way in which the female body is burdened with social and emotional expectations. With the series The (Dis-)Appearing Woman (2014–2015), Sarah Knill-Jones addresses the oscillation between appearance and disappearance through partially covered painted
More news about: Toutes les choses qu’elles portent; All The Things They Carry
Jan 12, 2026, 08:00 ET Sebela Pharmaceuticals® Announces Submission of New Drug Application to FDA for Tegoprazan for the Treatment of Gastroesophageal Reflux Disease
2014.2Chey WD, et al. Patient and physician satisfaction with proton pump inhibitors (PPIs): are there opportunities for improvement? Dig Dis Sci. 2010.3Armstrong D, et al. Symptom Profile, Proton Pump Inhibitor Therapy, and Diagnostic Testing in Patients with Persistent Reflux-Like
More news about: Sebela Pharmaceuticals
Jan 09, 2026, 09:43 ET Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly
SmPC Oczyesa®Colao A., et al. Acromegaly. Nat Rev Dis Primers. 2019;5(1):20.Webb SM, et al. Quality of Life in Acromegaly. Neuroendocrinology. 2016;103(1):106-111.Fleseriu
More news about: Camurus AB
Jan 09, 2026, 09:36 ET Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly
SmPC Oczyesa®Colao A., et al. Acromegaly. Nat Rev Dis Primers. 2019;5(1):20.Webb SM, et al. Quality of Life in Acromegaly. Neuroendocrinology. 2016;103(1):106-111.Fleseriu
More news about: Camurus AB
Jan 05, 2026, 15:45 ET OMNICOM MEDIA STUDY REVEALS NEW RULES FOR BRAND GROWTH IN THE ERA OF FRAGMENTED INFLUENCE
frictionless products/services access across digital and physical channels.Mental Availability depends on cutting through unprecedented noise and dis-intermediation in a marketplace where reach and frequency are just table stakes.Emotional Availability has emerged as a decisive lever for building
More news about: Omnicom Media